• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颅内血管痉挛、迟发性脑缺血以及动脉瘤性蛛网膜下腔出血后结局的遗传决定因素。

Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage.

机构信息

Department of Neurological Surgery, Columbia University, 630 West 168th Street, Room no. 5-454, New York, NY 10032, USA.

出版信息

J Cereb Blood Flow Metab. 2010 Apr;30(4):676-88. doi: 10.1038/jcbfm.2009.278. Epub 2010 Jan 13.

DOI:10.1038/jcbfm.2009.278
PMID:20068580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2949164/
Abstract

Despite extensive effort to elucidate the cellular and molecular bases for delayed cerebral injury after aneurysmal subarachnoid hemorrhage (aSAH), the pathophysiology of these events remains poorly understood. Recently, much work has focused on evaluating the genetic underpinnings of various diseases in an effort to delineate the contribution of specific molecular pathways as well as to uncover novel mechanisms. The majority of subarachnoid hemorrhage genetic research has focused on gene expression and linkage studies of these markers as they relate to the development of intracranial aneurysms and their subsequent rupture. Far less work has centered on the genetic determinants of cerebral vasospasm, the predisposition to delayed cerebral injury, and the determinants of ensuing functional outcome after aSAH. The suspected genes are diverse and encompass multiple functional systems including fibrinolysis, inflammation, vascular reactivity, and neuronal repair. To this end, we present a systematic review of 21 studies suggesting a genetic basis for clinical outcome after aSAH, with a special emphasis on the pathogenesis of cerebral vasospasm and delayed cerebral ischemia. In addition, we highlight potential pitfalls in the interpretation of genetic association studies, and call for uniformity of design of larger multicenter studies in the future.

摘要

尽管人们已经付出了大量努力来阐明蛛网膜下腔出血(aSAH)后迟发性脑损伤的细胞和分子基础,但这些事件的病理生理学仍知之甚少。最近,许多工作都集中在评估各种疾病的遗传基础上,以确定特定分子途径的贡献,并揭示新的机制。大多数蛛网膜下腔出血的遗传研究都集中在与颅内动脉瘤的发展及其随后的破裂相关的这些标志物的基因表达和连锁研究上。而关于脑血管痉挛、迟发性脑损伤易感性以及 aSAH 后功能结局的遗传决定因素的研究则少得多。可疑基因多种多样,涵盖了多个功能系统,包括纤维蛋白溶解、炎症、血管反应性和神经元修复。为此,我们对 21 项研究进行了系统综述,这些研究表明 aSAH 后的临床结果存在遗传基础,特别强调了脑血管痉挛和迟发性脑缺血的发病机制。此外,我们还强调了遗传关联研究解释中的潜在陷阱,并呼吁未来进行更大规模多中心研究时设计的统一性。

相似文献

1
Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage.颅内血管痉挛、迟发性脑缺血以及动脉瘤性蛛网膜下腔出血后结局的遗传决定因素。
J Cereb Blood Flow Metab. 2010 Apr;30(4):676-88. doi: 10.1038/jcbfm.2009.278. Epub 2010 Jan 13.
2
Nicardipine Prolonged Release Implants for Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.尼卡地平控释植入物预防动脉瘤性蛛网膜下腔出血后迟发性脑缺血:一项荟萃分析。
J Stroke Cerebrovasc Dis. 2021 Oct;30(10):106020. doi: 10.1016/j.jstrokecerebrovasdis.2021.106020. Epub 2021 Aug 5.
3
Lipid peroxidation metabolites as biomarkers in patients with aneurysmal subarachnoid hemorrhage and cerebral vasospasm or delayed cerebral ischemia: a systematic review.脂质过氧化代谢产物作为动脉瘤性蛛网膜下腔出血和脑血管痉挛或迟发性脑缺血患者的生物标志物:一项系统评价
Neurosurg Rev. 2025 Jun 20;48(1):516. doi: 10.1007/s10143-025-03662-3.
4
Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.他汀类药物治疗对动脉瘤性蛛网膜下腔出血患者血管痉挛、迟发性脑缺血和功能结局的影响:系统评价和荟萃分析更新。
Stroke. 2010 Jan;41(1):e47-52. doi: 10.1161/STROKEAHA.109.556332. Epub 2009 Oct 29.
5
Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.经颅多普勒检测到的血管痉挛可预测动脉瘤性蛛网膜下腔出血患者的迟发性脑缺血:一项系统评价和荟萃分析。
J Neurosurg. 2016 May;124(5):1257-64. doi: 10.3171/2015.4.JNS15428. Epub 2015 Oct 23.
6
Effects of Various Therapeutic Agents on Vasospasm and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage-Results of a Network Meta-Analysis.各种治疗药物对动脉瘤性蛛网膜下腔出血后血管痉挛和功能结局的影响——网络荟萃分析的结果。
World Neurosurg. 2021 Nov;155:41-53. doi: 10.1016/j.wneu.2021.07.104. Epub 2021 Jul 30.
7
Percutaneous cervical sympathetic block to treat cerebral vasospasm and delayed cerebral ischemia: a review of the evidence.经皮颈椎交感神经阻滞治疗脑血管痉挛和迟发性脑缺血:证据回顾。
J Neurointerv Surg. 2023 Dec;15(12):1212-1217. doi: 10.1136/jnis-2022-019838. Epub 2022 Dec 6.
8
Traumatic brain injury and intracranial hemorrhage-induced cerebral vasospasm: a systematic review.创伤性脑损伤和颅内出血引起的脑血管痉挛:系统评价。
Neurosurg Focus. 2017 Nov;43(5):E14. doi: 10.3171/2017.8.FOCUS17431.
9
Lessons Learned from Phase II and Phase III Trials Investigating Therapeutic Agents for Cerebral Ischemia Associated with Aneurysmal Subarachnoid Hemorrhage.从针对与颅内动脉瘤性蛛网膜下腔出血相关的脑缺血的治疗药物的 II 期和 III 期试验中吸取的经验教训。
Neurocrit Care. 2022 Apr;36(2):662-681. doi: 10.1007/s12028-021-01372-4. Epub 2021 Dec 23.
10
Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.内皮素受体拮抗剂治疗颅内动脉瘤性蛛网膜下腔出血:系统评价和荟萃分析更新。
Stroke. 2012 Oct;43(10):2671-6. doi: 10.1161/STROKEAHA.112.666693. Epub 2012 Aug 7.

引用本文的文献

1
The value of white blood cell count and platelet count in predicting delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.白细胞计数和血小板计数在预测动脉瘤性蛛网膜下腔出血后迟发性脑缺血中的价值。
Brain Spine. 2025 Mar 13;5:104236. doi: 10.1016/j.bas.2025.104236. eCollection 2025.
2
Treatment practice of vasospasm during endovascular thrombectomy: an international survey.血管痉挛治疗实践:血管内血栓切除术的国际调查。
Stroke Vasc Neurol. 2024 Nov 5;9(5):490-496. doi: 10.1136/svn-2023-002788.
3
Cromolyn prevents cerebral vasospasm and dementia by targeting WDR43.色甘酸钠通过作用于WDR43来预防脑血管痉挛和痴呆。
Front Aging Neurosci. 2023 Apr 13;15:1132733. doi: 10.3389/fnagi.2023.1132733. eCollection 2023.
4
Molecular hydrogen therapy for neurological diseases: a review of current evidence.分子氢治疗神经系统疾病:当前证据综述。
Med Gas Res. 2023 Jul-Sep;13(3):94-98. doi: 10.4103/2045-9912.359677.
5
Automated Quantification of Compartmental Blood Volumes Enables Prediction of Delayed Cerebral Ischemia and Outcomes After Aneurysmal Subarachnoid Hemorrhage.自动量化分腔血容量可预测动脉瘤性蛛网膜下腔出血后迟发性脑缺血和结局。
World Neurosurg. 2023 Feb;170:e214-e222. doi: 10.1016/j.wneu.2022.10.105. Epub 2022 Oct 30.
6
Genetic variation in NFE2L2 is associated with outcome following aneurysmal subarachnoid haemorrhage.NFE2L2 基因变异与动脉瘤性蛛网膜下腔出血的预后相关。
Eur J Neurol. 2023 Jan;30(1):116-124. doi: 10.1111/ene.15571. Epub 2022 Oct 2.
7
methylation and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage patients.动脉瘤性蛛网膜下腔出血患者的甲基化与迟发性脑缺血
Epigenetics Commun. 2021;1. doi: 10.1186/s43682-021-00001-7. Epub 2021 Dec 20.
8
Network Pharmacology Reveals the Mechanism of Activity of Tongqiao Huoxue Decoction Extract Against Middle Cerebral Artery Occlusion-Induced Cerebral Ischemia-Reperfusion Injury.网络药理学揭示通窍活血汤提取物抗大脑中动脉闭塞诱导的脑缺血再灌注损伤的作用机制
Front Pharmacol. 2021 Jan 11;11:572624. doi: 10.3389/fphar.2020.572624. eCollection 2020.
9
Hydrogen Inhalation Attenuates Oxidative Stress Related Endothelial Cells Injury After Subarachnoid Hemorrhage in Rats.氢气吸入减轻大鼠蛛网膜下腔出血后氧化应激相关的内皮细胞损伤
Front Neurosci. 2020 Jan 21;13:1441. doi: 10.3389/fnins.2019.01441. eCollection 2019.
10
Genetic Insights into Cerebrovascular Disorders: A Comprehensive Review.脑血管疾病的遗传学见解:全面综述
J Vasc Interv Neurol. 2017 Oct;9(5):21-32.

本文引用的文献

1
Genes influencing coagulation and the risk of aneurysmal subarachnoid hemorrhage, and subsequent complications of secondary cerebral ischemia and rebleeding.影响凝血和动脉瘤性蛛网膜下腔出血风险的基因,以及随后的继发性脑缺血和再出血并发症。
Acta Neurochir (Wien). 2010 Feb;152(2):257-62. doi: 10.1007/s00701-009-0505-0. Epub 2009 Oct 14.
2
Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.颅内动脉瘤性蛛网膜下腔出血后血管痉挛、脑灌注与迟发性脑缺血的关系。
Neuroradiology. 2009 Dec;51(12):813-9. doi: 10.1007/s00234-009-0575-y. Epub 2009 Jul 22.
3
Endothelial nitric oxide synthase polymorphisms and haplotypes in Amerindians.美洲印第安人体内的内皮型一氧化氮合酶基因多态性与单倍型
DNA Cell Biol. 2009 Jul;28(7):329-34. doi: 10.1089/dna.2009.0878.
4
Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage.皮质扩展性缺血是一种与动脉瘤性蛛网膜下腔出血患者缺血性损伤相关的新过程。
Brain. 2009 Jul;132(Pt 7):1866-81. doi: 10.1093/brain/awp102. Epub 2009 May 6.
5
Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?蛛网膜下腔出血后血管痉挛的定义:最具临床相关性的定义是什么?
Stroke. 2009 Jun;40(6):1963-8. doi: 10.1161/STROKEAHA.108.544700. Epub 2009 Apr 9.
6
Apolipoprotein E genotype and outcome after aneurysmal subarachnoid hemorrhage.载脂蛋白E基因型与动脉瘤性蛛网膜下腔出血后的预后
J Neurosurg. 2009 May;110(5):989-95. doi: 10.3171/2008.11.JNS081266.
7
Association between factor XIII single nucleotide polymorphisms and aneurysmal subarachnoid hemorrhage.凝血因子 XIII 单核苷酸多态性与动脉瘤性蛛网膜下腔出血之间的关联。
J Neurosurg. 2009 Mar;110(3):475-81. doi: 10.3171/2008.7.JNS08272.
8
Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage.蛛网膜下腔出血后血管痉挛所致无症状性脑梗死的发生率及临床影响
J Neurosurg. 2008 Dec;109(6):1052-9. doi: 10.3171/JNS.2008.109.12.1052.
9
APOE genotype and functional outcome following aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血后的载脂蛋白E基因型与功能转归
Biol Res Nurs. 2009 Jan;10(3):205-12. doi: 10.1177/1099800408323221. Epub 2008 Nov 17.
10
Relationship of the Met allele of the brain-derived neurotrophic factor Val66Met polymorphism to memory after aneurysmal subarachnoid hemorrhage.脑源性神经营养因子Val66Met多态性的Met等位基因与动脉瘤性蛛网膜下腔出血后记忆的关系。
Neurosurgery. 2008 Aug;63(2):198-203; discussion 203. doi: 10.1227/01.NEU.0000320382.21577.8E.